Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 18th Apr'24 to 28th Apr'24
New GCP Compliance Requirements for Clinical QMS
What is a Clinical Quality Management System?
- Regulatory drive for CQMS: ICH Q10, EMA Quality Systems
- ISO 900, ISO Devices, FDA perspective, ICH E6 (R2)
Proposed ICH CQMS – CQMS Framework
- What are the components of a CQMS
Compliance Deficiencies including CQMS
- What are inspectors looking for?
- Feedback from the regulators - hot inspection topics and trends
Documentation supporting quality and Data Integrity in CQMS
- What documents should be in place?
Governance of CQMS
- The role of Senior Management
- Management review
Importance of Key Performance Indicators (KPIs) in your QMS
Overview of the webinar
Currently pharmaceutical and medical device industry guidance for quality in clinical development is fractured across multiple documents from multiple sources. Also, with the implementation of ICH GCP R2, it is expected that the CQMS should be risk-based.
Regulatory inspectors including those in Europe, the FDA and UK’s MHRA now expect a CQMS to be in place. However, there is no industry-wide conceptual framework for clinical Quality Management that aims to address quality and monitor and improve performance in complex clinical development-specific environments. More developed systems exist in other departments such as manufacturing and pharmacovigilance.
Organizations are struggling to implement the QMS standards such as ISO 9000 principles, ICH 10 for CQMS and also some ICH R2 CQMS requirements are proving challenging. Since there is currently no harmonized regulatory guidance defining elements of a CQMS framework there is a proposal for a new ICH guideline to cover CQMS.
This session is designed to help in both the compliance with inspectors expectations for CQMS and share best practice for CQMS including a new proposed unified standard CQMS framework.
Who should attend?
This course is aimed at anyone working in clinical research and associated functions including regulatory affairs, document management etc who need to know how to establish, maintain, monitor and improve a modern CQMS that focuses on product quality, compliance to GCP and the needs of the business.
This course is also of value to any Quality Professional, especially those working in Quality Assurance and Quality Improvement roles in clinical research, management responsible for the governance of CQMS and anyone working with or in clinical research who needs to comply with the new requirements for CQMS including study sites.
It is ideal for those implementing a CQMS, those wanting to share best practice for CQMS and also anyone wanting to know about the new harmonized standard proposed for CQMS.
Why should you attend?
- Understand clinical Quality Management Systems (CQMS)
- Review the new proposed CQMS framework
- Discuss the importance of Key Performance Indicators (KPIs) in your CQMS
- Ensure compliance with CQMS expectations of inspectors
Faculty - Dr.Laura Brown
Dr. Laura Brown is an independent Pharmaceutical QA, Management and Training Consultant and Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. Laura has more than 20 years' experience of Quality Assurance and managing international clinical trials including risk identification and management. She has worked for several companies including GSK, Hoechst Marion Roussel, Good Clinical Research Practices and Phoenix International. She has consulted with numerous pharmaceutical companies, suppliers to the pharmaceutical industry as well as academic institutions.
Dr. Brown has an MBA with specialization in project management including risk management. She is also the external project management expert for a pharmaceutical e-learning MSc module in project management covering risk management and the author of two books on project management including the leading book “Pharmaceutical Project Management” (Gower).